Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

Moss, 26 November 2024

The CEO of Gentian Diagnostics, Mr. Matti Heinonen, will today give a company presentation at the DNB Nordic Healthcare conference.

Please find the presentation here.

For further information, please contact:

Njaal Kind CFO, Gentian Diagnostics ASA
E-mail: njaal.kind@gentian.no
+47 919 06 525

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..